Production (Stage)
Journey Medical Corporation
DERM
$7.39
-$0.15-1.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.14M | 12.62M | 14.63M | 14.86M | 13.03M |
| Total Other Revenue | -- | 1.00M | -- | -- | -- |
| Total Revenue | 13.14M | 13.62M | 14.63M | 14.86M | 13.03M |
| Cost of Revenue | 4.79M | 2.24M | 5.29M | 6.54M | 6.00M |
| Gross Profit | 8.35M | 11.38M | 9.34M | 8.31M | 7.03M |
| SG&A Expenses | 10.57M | 10.06M | 11.40M | 10.33M | 8.42M |
| Depreciation & Amortization | 1.07M | 3.42M | -- | -- | 814.00K |
| Other Operating Expenses | -- | -4.55M | -- | -- | -- |
| Total Operating Expenses | 16.46M | 11.39M | 17.52M | 17.78M | 23.12M |
| Operating Income | -3.32M | 2.23M | -2.89M | -2.93M | -10.09M |
| Income Before Tax | -4.07M | 1.58M | -2.39M | -3.36M | -10.44M |
| Income Tax Expenses | -- | 61.00K | -- | -- | -- |
| Earnings from Continuing Operations | -4.07M | 1.52M | -2.39M | -3.36M | -10.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.07M | 1.52M | -2.39M | -3.36M | -10.44M |
| EBIT | -3.32M | 2.23M | -2.89M | -2.93M | -10.09M |
| EBITDA | -2.26M | 3.22M | -2.08M | -2.11M | -9.28M |
| EPS Basic | -0.18 | 0.07 | -0.12 | -0.17 | -0.53 |
| Normalized Basic EPS | -0.11 | 0.05 | -0.11 | -0.11 | -0.33 |
| EPS Diluted | -0.18 | 0.07 | -0.12 | -0.17 | -0.53 |
| Normalized Diluted EPS | -0.11 | 0.05 | -0.11 | -0.11 | -0.33 |
| Average Basic Shares Outstanding | 22.61M | 21.31M | 20.54M | 19.99M | 19.76M |
| Average Diluted Shares Outstanding | 22.61M | 21.31M | 20.54M | 19.99M | 19.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |